MRG003 and Pucotenlimab to Treat Locally Advanced or Metastatic ATC/PDTC
MRG003 and Pucotenlimab to Treat Locally Advanced or Metastatic ATC/PDTC
Recruiting · NCT07235566 · Registry updated 2025-11-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| MRG003 and Pucotenlimab to Treat Locally Advanced or Metastatic ATC/PDTC | Head and Neck Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, neoplasm, thyroid gland disorder, thyroid tumor | Recruiting | Phase 2 | 2025-11-19 | NCT07235566 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fudan University | 653 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fudan University Shanghai Cancer Center | Shanghai | China | 85 |